| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042321153 |
| P356 | DOI | 10.1023/A:1014448721327 |
| P698 | PubMed publication ID | 11949826 |
| P50 | author | Michael Weller | Q2779469 |
| P2093 | author name string | Johannes Rieger | |
| Andreas Rimner | |||
| Ulrike Naumann | |||
| Johannes R Streffer | |||
| Hans-Peter Rodemann | |||
| P2860 | cites work | APO2 ligand: a novel lethal weapon against malignant glioma? | Q28272697 |
| Tumor radiosensitivity and apoptosis | Q33545681 | ||
| The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation | Q34040856 | ||
| Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation | Q34223630 | ||
| BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy | Q35454275 | ||
| The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression | Q36736035 | ||
| Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes | Q44117460 | ||
| Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy | Q47784613 | ||
| Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax. | Q48088809 | ||
| Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults | Q48303492 | ||
| Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. | Q48334505 | ||
| BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study | Q48482815 | ||
| Overexpression of bax in human glioma cell lines. | Q54080419 | ||
| Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions. | Q55476041 | ||
| Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status. | Q55476394 | ||
| PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. | Q55476772 | ||
| Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis | Q71216333 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 43-49 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells | |
| P478 | volume | 56 |
| Q36954853 | Abrin P2 suppresses proliferation and induces apoptosis of colon cancer cells via mitochondrial membrane depolarization and caspase activation |
| Q40511785 | Alkylphosphocholine-induced glioma cell death is BCL-X(L)-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formation |
| Q33898584 | Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma |
| Q36021584 | Apoptosis in gliomas: molecular mechanisms and therapeutic implications |
| Q39912647 | Apoptosis induced by baicalin involving up-regulation of P53 and bax in MCF-7 cells |
| Q48122093 | BCL-XL overexpression promotes tumor progression-associated properties. |
| Q34732893 | Bcl-xL overexpression and its association with the progress of tongue carcinoma |
| Q44736357 | Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy |
| Q33791364 | Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study. |
| Q37079878 | Chemoresistance in gliomas |
| Q36343757 | Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1 |
| Q38964722 | Effects of crude extracts from medicinal herbs Rhazya stricta and Zingiber officinale on growth and proliferation of human brain cancer cell line in vitro |
| Q38101608 | Enhancing radiation therapy for patients with glioblastoma |
| Q33266642 | Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells |
| Q93185415 | Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy |
| Q97540974 | Methyl cellosolve-induced renal oxidative stress and time-dependent up-regulation of pro-inflammatory cytokines, apoptotic, and oncogenic markers in rats |
| Q34648569 | MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury |
| Q35208840 | Molecular markers in clinical radiation oncology |
| Q35594029 | Novel chemotherapeutic agents for the treatment of glioblastoma multiforme |
| Q34886884 | Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival. |
| Q39352683 | Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr |
| Q42277834 | The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. |
| Q34988117 | The RNA-binding protein HuR promotes glioma growth and treatment resistance. |
| Q26851645 | The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond |
| Q37736329 | The role of mitochondria in glioma pathophysiology |
| Q28299334 | The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression |
Search more.